Ivermectin in the treatment of COVID-19-friend or foe?

被引:0
|
作者
Schellack, N. [1 ]
Padayachee, N. [2 ]
Schellack, G. [3 ]
机构
[1] Univ Pretoria, Pretoria, South Africa
[2] Univ Witwatersrand, Clin Pharm, Dept Pharm & Pharmacol, Johannesburg, South Africa
[3] Clin Res & Appl Pharmacol, Cape Town, South Africa
关键词
COVID-19; SARS-CoV-2; ivermectin; avermectin; macrocyclic lactone; endectocide; ADVERSE-REACTIONS; SAFETY; PHARMACOKINETICS; PROTEIN; DENGUE; DRUG;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The global number of deaths due to COVID-19 is almost at the two million mark, with over 35 000 deaths in South Africa. Although there are hopes of a safe and effective vaccination programme, the increasing number of COVID-19 cases in the country is putting a significant strain on the healthcare system. Ivermectin, an antiparasitic drug, has been widely published on social media platforms and news outlets as a so-called miracle drug for the treatment of COVID-19. Ivermectin is not registered in SA as a drug for human use, but rather as a veterinary and agricultural product. Currently, from a small number of randomised controlled trials (RCTs), there does seem to be a signal of evidence for the use of ivermectin in the management of COVID-19. Pharmacists must, however, remain cognisant of their ethical responsibilities as well as the applicable regulations that prohibit the procurement and dispensing of any unregistered medicine.
引用
收藏
页码:11 / +
页数:5
相关论文
共 50 条
  • [1] Monocytes and macrophages in severe COVID-19-friend, foe or both?
    Dress, Regine J.
    Ginhoux, Florent
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (06): : 561 - 564
  • [2] Glucocorticoids in COVID19; a friend not foe
    Owlia, Sina
    Owlia, Mohammad Bagher
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [3] Testosterone in COVID-19: Friend or Foe?
    Peter J. Niemann
    Heidi V. Goldstein
    [J]. Endocrine, 2021, 71 : 281 - 282
  • [4] NSAIDs in COVID-19, friend or foe?
    Victor, Robert
    Kelly, Richard
    Cockrill, Ryan
    Katrivesis, Karen
    Nelson, Corey
    Rajan, Govind
    [J]. ANAESTHESIA PAIN & INTENSIVE CARE, 2022, 26 (04) : 546 - 550
  • [5] Estrogen and COVID-19: friend or foe?
    Di Vincenzo, A.
    Andrisani, A.
    Vettor, R.
    Rossato, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (07) : 934 - 934
  • [6] The COVID-19 facemask: Friend or foe?
    Hallock, Geoffrey G.
    [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2021, 74 (05): : 1149 - 1150
  • [7] Testosterone in COVID-19: Friend or Foe?
    Niemann, Peter J.
    Goldstein, Heidi V.
    [J]. ENDOCRINE, 2021, 71 (02) : 281 - 282
  • [8] NSAIDs in COVID-19, friend or foe?
    Mahrous, Reham
    Abdelnasser, Amr
    Fouda, Raghda
    Morsy, Mohamed Abd Al Moniem
    Mandour, Omnia
    [J]. ANAESTHESIA PAIN & INTENSIVE CARE, 2023, 27 (01) : 119 - 122
  • [9] COVID-19 and diabetes: Is metformin a friend or foe?
    Ursini, Francesco
    Ciaffi, Jacopo
    Landini, Maria Paola
    Meliconi, Riccardo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164
  • [10] The complement system in COVID-19: friend and foe?
    Java, Anuja
    Apicelli, Anthony J.
    Liszewski, M. Kathryn
    Coler-Reilly, Ariella
    Atkinson, John P.
    Kim, Alfred H. J.
    Kulkarni, Hrishikesh S.
    [J]. JCI INSIGHT, 2020, 5 (15)